Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis
PLOS ONE · 26.10.2023 · 18 (10) · e0292974
DOI: 10.1371/journal.pone.0292974 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 26.10.2023. Verfasst von Jeffrey Curran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Queen's University, Kingston, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiac Surgical Procedures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Atrial fibrillation (AF) is the most common cardiac arrhythmia in intensive care units (ICU) and is associated with increased morbidity and mortality. Magnesium prophylaxis has been shown to reduce incidence of AF in cardiac surgery patients, however, evidence outside this population is limited. The objective of this study is to summarize studies examining magnesium versus placebo in the prevention of NOAF outside the setting of cardiac surgery. Source We performed a comprehensive search of MEDLINE, EMBASE, and Cochrane Library (CENTRAL) from inception until January 3 rd , 2023. We included all interventional research studies that compared magnesium to placebo and excluded case reports and post cardiac surgery patients. We conducted meta-analysis using the inverse variance method with random effects modelling. Principal findings Of the 1493 studies imported for screening, 87 full texts were assessed for eligibility and six citations, representing five randomized controlled trials (n = 4713), were included in the review, with four studies (n = 4654) included in the pooled analysis. Administration of magnesium did not significantly reduce the incidence of NOAF compared to placebo (OR 0.72, [95% CI 0.48 to 1.09]).
Conclusion
Use of magnesium did not reduce the incidence of NOAF, however these studies represent diverse groups and are hindered by significant bias. Further studies are necessary to determine if there is benefit to magnesium prophylaxis for NOAF in non-cardiac surgery patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Queen's University, Kingston, Canada.
- Bracken Health Sciences Library, Queen's University, Kingston, Canada.
ORCID-Profile: Stephanie Sibley
Zitieren
APA
Curran, J., Ross-White, A., & Sibley, S. (2023). Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis. PLOS ONE, 18(10), e0292974. https://doi.org/10.1371/journal.pone.0292974
Vancouver
Curran J, Ross-White A, Sibley S. Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis. PLOS ONE. 2023;18(10):e0292974. doi:10.1371/journal.pone.0292974
BibTeX
@article{Curran2023,
author = {Curran, Jeffrey and Ross-White, Amanda and Sibley, Stephanie},
title = {Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {10},
pages = {e0292974},
doi = {10.1371/journal.pone.0292974}
}
EUVIMED